Gut Health Research

A specific bacterium residing in the gut, Akkermansia muciniphila , is emerging as a central player in metabolic health

Pathophysiology-Driven Natural Approaches for IBS-C Management Irritable Bowel Syndrome with constipation (IBS-C) involves more than infrequent bowel mo…

Beyond Fiber: A Pathophysiology-Driven Approach to Managing IBS-C Irritable Bowel Syndrome with constipation (IBS-C) is more than slow transit; it’s a d…

Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where chronic abdominal pain and bloating accompany difficult, infrequent bowel…

Introduction A complex axis linking the gut microbiome, immune function, and metabolic health is emerging as a fundamental factor in conditions ranging …

Introduction Irritable bowel syndrome with constipation (IBS-C) involves more than infrequent bowel movements

Irritable bowel syndrome with constipation (IBS-C) is not simply a slow-moving gut

Beyond Fiber: A Pathophysiology-Driven Approach to IBS-C Treatment Irritable bowel syndrome with constipation (IBS-C) is more than a motility problem

Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where abdominal pain and infrequent bowel movements stem from multiple interact…

Beyond Linaclotide: New Evidence on IBS-C Relief via Gut-Brain Axis Irritable Bowel Syndrome with constipation (IBS-C) is a complex, multifactorial diso…

Microsatellite-stable (MSS) colorectal cancer is the most common form of the disease, accounting for roughly 85% of cases. Unlike its microsatellite instability–high (MSI-H) counterpart, MSS CRC remains stubbornly resistant to immunotherapy drugs known as immune checkpoint blockade (ICB). New research argues this resistance is not simply due to a lack of immune cells, but is…

Pathophysiology-Driven IBS-C Management: A 2026 Look at Natural Products and Meal Timing Irritable Bowel Syndrome with constipation (IBS-C) remains a co…